As of the latest SEC filings, Monopar Therapeutics (MNPR) is held by 95 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $9,203,952.94 in market value, representing a significant portion of its portfolio.
Funds holding Monopar Therapeutics (MNPR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MNPR
- CIK:
- 0001645469
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $9,203,952.94 | 167,986 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $5,992,437.09 | 109,371 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,436,511.30 | 44,470 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $2,278,068.45 | 43,683 | Apr 30, 2026 | Jun 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.02% | $1,931,457.08 | 35,252 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.02% | $1,886,310.12 | 34,428 | Mar 31, 2026 | May 28, 2026 |
|
SDSCX
BNY Mellon Small/Mid Cap Growth Fund
|
MF | Independent / Boutique | 0.19% | $1,436,265.06 | 26,214 | Mar 31, 2026 | May 21, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $1,238,593.00 | 22,600 | Feb 28, 2026 | Apr 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,140,930.49 | 20,818 | Feb 28, 2026 | Apr 24, 2026 |
|
NBMOX
Neuberger Small Cap Growth Fund
|
MF | Neuberger Berman | 0.22% | $1,092,976.12 | 19,943 | Feb 28, 2026 | Apr 24, 2026 |
|
VFMO
VANGUARD U.S. MOMENTUM FACTOR ETF
|
ETF | Vanguard | 0.08% | $1,082,617.97 | 19,754 | Feb 28, 2026 | Apr 28, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.05% | $609,867.49 | 11,131 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $498,449.70 | 9,558 | Apr 30, 2026 | Jun 25, 2026 |
|
-
Master Small Cap Index Series
|
ETF | Independent / Boutique | 0.01% | $423,910.23 | 7,737 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $394,157.56 | 7,192 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $315,567.19 | 5,758 | Feb 28, 2026 | Apr 24, 2026 |
|
TRHBX
Nuveen Small Cap Blend Index Fund
|
MF | TIAA / Nuveen | 0.01% | $289,484.65 | 5,551 | Apr 30, 2026 | Jun 24, 2026 |
|
-
EQ/2000 Managed Volatility Portfolio
|
ETF | Independent / Boutique | 0.01% | $267,265.62 | 4,878 | Mar 31, 2026 | May 26, 2026 |
|
GSSC
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF
|
ETF | Goldman Sachs | 0.03% | $262,351.54 | 4,787 | Feb 28, 2026 | Apr 28, 2026 |
|
RSCRX
U.S. Small Cap Equity Fund
|
MF | Russell Investments | 0.03% | $255,847.90 | 4,906 | Apr 30, 2026 | Jun 22, 2026 |
|
VTWG
VANGUARD RUSSELL 2000 GROWTH INDEX FUND
|
ETF | Vanguard | 0.02% | $229,852.17 | 4,194 | Feb 28, 2026 | Apr 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $224,426.48 | 4,095 | Feb 28, 2026 | Apr 24, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.52% | $192,902.85 | 3,699 | Apr 30, 2026 | Jun 22, 2026 |
|
FECGX
Fidelity Small Cap Growth Index Fund
|
MF | Fidelity | 0.02% | $183,930.03 | 3,357 | Mar 31, 2026 | May 26, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $167,931.35 | 3,065 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)